Live Breaking News & Updates on Chrystal Ferguson|Page 2

Stay updated with breaking news from Chrystal ferguson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Apellis Ushers in a New Era of Geographic Atrophy Treatment with First Ever Approval, According to Spherix Global Insights

/PRNewswire/ Apellis Pharmaceuticals recently made history with the approval of Syfovre (pegcetacoplan) for the treatment for Geographic Atrophy (GA). GA is. ....

Chrystal Ferguson , Iveric Bio , Scott Upham , Apellis Pharmaceuticals , Corporate Communications , Spherix Network , Spherix Global Insights , Geographic Atrophy , Global Insights , Senior Insights Director , Spherix Global Insight ,

Switching Patterns Among Diabetic Macular Edema: Regeneron's Eylea Withstands the Evolving DME Switch Landscape

/PRNewswire/ The patient switch territory is evolving as more agents become available. Spherix s RealWorld Dynamix™ report allows for an inside look into. ....

Novartis Beovu , Chrystal Ferguson , Coherus Bioscience Cimerli , Scott Upham , Genentech Vabysmo , Corporate Communications , Spherix Network , Realworld Dynamix , Biologic Switches , Diabetic Macular Edema , Coherus Bioscience , World Dynamix , Global Insights , Spherix Global Insights , Global Insights Contacts , Insights Director ,

Spherix Global Insights Announces Special Coverage of Amgen's Amjevita Launch, Tracking Uptake and Perceptions of the First Commercially-available Biosimilar to AbbVie's Humira

/PRNewswire/ AbbVie s Humira (adalimumab) is the world s best selling drug, but the entry of biosimilar challengers, with Amgen s Amjevita being the first. ....

United States , Amgen Amjevita , Amgen Avsola , Coheru Yusimry , Scott Upham , July Boehringer Ingelheim Cyltezo , Abbvie Humira , Chrystal Ferguson , Merck Renflexis , Corporate Communications , Spherix Network , Special Topix , Biosimilars Today , Boehringer Ingelheim , Global Insights , Spherix Global Insights , Global Insights Contacts , Insights Director ,

Switching Patterns Among Neovascular Age-Related Macular Degeneration: Genentech's Vabysmo Rising, Regeneron's Eylea and Genentech's Off-Label Avastin Remain Strong, According to Spherix Global Insights

/PRNewswire/ The switch landscape represents an active segment of the market where brands have the opportunity to capture share. Spherix s RealWorld. ....

Coherus Bioscience Cimerli , Genentech Susvimo , Scott Upham , Genentech Vabysmo , Regeneron Eylea , Chrystal Ferguson , Genentech Lucentis , Samsung Byooviz , Biosimilars Byooviz , Corporate Communications , Spherix Network , Realworld Dynamix , Biologic Switches , Neovascular Age Related Macular Degeneration , Coherus Bioscience , World Dynamix , Global Insights , Spherix Global Insights , Global Insights Contacts , Insights Director ,

Implications of Biosimilar Availability in the United States' Ophthalmology Markets Highlighted in New Spherix Global Insights Study

/PRNewswire/ Ophthalmologists saw the entry of the first biosimilars into the armamentarium in 2022 with the launch of Biogen and Samsung s Byooviz and. ....

Coherus Bioscience Cimerli , Viatrisa Mylan , Scott Upham , Regeneron Eylea , Chrystal Ferguson , Genentech Lucentis , Coherus Biosciences , Samsung Byooviz , Corporate Communications , Spherix Network , Coherus Bioscience , Special Topix , Biosimilars Today , High Dose , Global Insights , Spherix Global Insights , Global Insights Contacts , Insights Director ,